In addition, it has been reported that cellular resistance to platinum drugs and PARP inhibitors in BRCA1-defective cancer cells is caused by overexpression of a microRNA(miR-622)-mediated regulation of NHEJ [141]. Here, BRCA1 is linked to cancer.